GS0051: diagnostic preparation and reagents for clinical or medical laboratory use, namely, biotechnological compounds and substances designed to provide functional assays of genes, perform gene sequencing and assist in genetic mapping and analysis of human, plant and animal genomes; pharmaceutical compounds, therapeutic and diagnostic agents and other biotechnologic substances incorporating the results of genomic research, namely, drugs and anti-infective agents for combating resistant infectious diseases for human and veterinary applications
GS0091: scientific instruments, namely, DNA sequence analyzers, micro-arrays, bio-chips, micro-chips, computer hardware, and electronic databases recorded on computer media all designed to provide functional assays of genes, perform gene sequencing and assist in genetic mapping and analysis of human and animal genomes
GS0421: biotechnology research services and development of new products for others in the field of genome research, genetic mapping of genetic and infectious diseases, single nucleotide polymorphism (snp) detection, performing functional assays of genes and sequencing genes
TF0000: as to "GENOME THERAPEUTICS"
Case File Event Statements
4/15/2011 - 13 years ago
15 - CANCELLED SEC. 8 (6-YR)Type:C8..
9/14/2004 - 20 years ago
14 - REGISTERED-PRINCIPAL REGISTERType:R.PR
6/17/2004 - 20 years ago
13 - Sec. 1(B) CLAIM DELETEDType:1.BD
6/16/2004 - 20 years ago
12 - NOTICE OF ALLOWANCE CANCELLEDType:IUCN
6/16/2004 - 20 years ago
11 - FAX RECEIVEDType:FAXX
12/16/2003 - 21 years ago
10 - NOA MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
9/23/2003 - 21 years ago
9 - PUBLISHED FOR OPPOSITIONType:PUBO
9/3/2003 - 21 years ago
8 - NOTICE OF PUBLICATIONType:NPUB
7/29/2003 - 21 years ago
7 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
5/20/2003 - 21 years ago
6 - Sec. 1(B) CLAIM ADDEDType:1.BA
5/20/2003 - 21 years ago
5 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA